These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
304 related items for PubMed ID: 22429755
1. Atypical forms of Guillain-Barré syndrome and H1N1-influenza vaccination. Shaikh AG, Termsarasab P, Nwankwo C, Rao-Frisch A, Katirji B. Vaccine; 2012 May 09; 30(22):3251-4. PubMed ID: 22429755 [Abstract] [Full Text] [Related]
2. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2010 Jun 04; 59(21):657-61. PubMed ID: 20520590 [Abstract] [Full Text] [Related]
3. Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010. Polakowski LL, Sandhu SK, Martin DB, Ball R, Macurdy TE, Franks RL, Gibbs JM, Kropp GF, Avagyan A, Kelman JA, Worrall CM, Sun G, Kliman RE, Burwen DR. Am J Epidemiol; 2013 Sep 15; 178(6):962-73. PubMed ID: 23652165 [Abstract] [Full Text] [Related]
4. Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009). Souayah N, Yacoub HA, Khan HM, Michas-Martin PA, Menkes DL, Maybodi L, Qureshi AI. Neuroepidemiology; 2012 Sep 15; 38(4):227-32. PubMed ID: 22555646 [Abstract] [Full Text] [Related]
5. Are the atypical forms of Guillain-Barré syndrome correlated with H1N1-influenza vaccination? Li S, Zhu J. Vaccine; 2012 Aug 17; 30(38):5585. PubMed ID: 22728223 [No Abstract] [Full Text] [Related]
6. Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition. Choe YJ, Cho H, Bae GR, Lee JK. Vaccine; 2011 Mar 03; 29(11):2066-70. PubMed ID: 21255684 [Abstract] [Full Text] [Related]
10. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, Zuber P, Hua W, Bonhoeffer J, Buttery J, Crawford N, Deceuninck G, de Vries C, De Wals P, Gutierrez-Gimeno MV, Heijbel H, Hughes H, Hur K, Hviid A, Kelman J, Kilpi T, Chuang SK, Macartney K, Rett M, Lopez-Callada VR, Salmon D, Gimenez-Sanchez F, Sanz N, Silverman B, Storsaeter J, Thirugnanam U, van der Maas N, Yih K, Zhang T, Izurieta H, Global H1N1 GBS Consortium. Vaccine; 2013 Sep 13; 31(40):4448-58. PubMed ID: 23770307 [Abstract] [Full Text] [Related]
11. Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series. Andrews N, Stowe J, Al-Shahi Salman R, Miller E. Vaccine; 2011 Oct 19; 29(45):7878-82. PubMed ID: 21875631 [Abstract] [Full Text] [Related]
17. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005). Souayah N, Nasar A, Suri MF, Qureshi AI. J Clin Neuromuscul Dis; 2009 Sep 19; 11(1):1-6. PubMed ID: 19730016 [Abstract] [Full Text] [Related]
19. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe. Romio S, Weibel D, Dieleman JP, Olberg HK, de Vries CS, Sammon C, Andrews N, Svanström H, Mølgaard-Nielsen D, Hviid A, Lapeyre-Mestre M, Sommet A, Saussier C, Castot A, Heijbel H, Arnheim-Dahlström L, Sparen P, Mosseveld M, Schuemie M, van der Maas N, Jacobs BC, Leino T, Kilpi T, Storsaeter J, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC. PLoS One; 2014 Sep 19; 9(1):e82222. PubMed ID: 24404128 [Abstract] [Full Text] [Related]